ORMP

Oramed Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Oramed Pharmaceuticals Inc ORMP NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.21 -4.87% 4.10 19:34:00
Open Price Low Price High Price Close Price Previous Close
4.27 4.08 4.31 4.17 4.31
more quote information »

Recent News

Date Time Source Heading
12/02/202008:43EDGARCurrent Report Filing (8-k)
12/02/202008:25PRNUSOramed Initiates Phase 2 NASH Trial of Oral Insulin
12/01/202017:24EDGARCurrent Report Filing (8-k)
11/24/202008:10PRNUSOramed Initiates Phase 3 Trial of Oral Insulin
11/24/202007:38EDGARAnnual Report (10-k)
11/12/202008:40PRNUSNobel Laureate, Oramed SAB member Prof. Avram Hershko and..
11/10/202008:25PRNUSOramed to Present at H.C. Wainwright 6th Annual Israel..
10/28/202008:40PRNUSOramed to Present Phase 2b Oral Insulin Data at American..
10/27/202008:55PRNUSOramed CEO Nadav Kidron & Premas Biotech to Host Webinar..
10/22/202016:06EDGARCurrent Report Filing (8-k)
10/16/202008:40PRNUSOramed Issues Shareholder Update on Pivotal Phase 3 Oral..
9/21/202008:25PRNUSOramed Pharmaceuticals to Present at the European..
9/15/202008:25PRNUSOramed's Diabetes Market Survey Shows Strong Support for..
9/09/202016:14EDGARCurrent Report Filing (8-k)
9/03/202008:10PRNUSOramed to Present at H.C. Wainwright Global Investment..
8/27/202016:44EDGARCurrent Report Filing (8-k)
8/11/202016:40EDGARSecurities Registration: Employee Benefit Plan (s-8)
7/15/202009:17EDGARCurrent Report Filing (8-k)
7/15/202008:55PRNUSOramed Reports Positive End of Phase 2 Meeting With the FDA..
7/07/202016:14EDGARQuarterly Report (10-q)
6/30/202016:10EDGARProxy Statement (definitive) (def 14a)
6/16/202016:28EDGARProxy Statement - Notice of Shareholders Meeting..
6/15/202008:25PRNUSOramed Announces Positive Initial Clinical Trial Results for..
5/05/202007:55PRNUSOramed Pharmaceuticals to Present at the 80th American..
5/01/202011:17EDGARConfidential Treatment Order (ct Order)
5/01/202011:15EDGARConfidential Treatment Order (ct Order)
4/09/202016:43EDGARCurrent Report Filing (8-k)
4/07/202007:40PRNUSOramed Patent in Canada Allowed for Oral Delivery of..
4/06/202016:47EDGARQuarterly Report (10-q)
4/01/202008:40PRNUSOramed Pharmaceuticals Issues CEO Shareholder Letter..
3/19/202008:40PRNUSOramed Receives Positive Feedback From End-of-Phase 2 Oral..
3/02/202011:45EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/28/202013:11EDGARCurrent Report Filing (8-k)
2/27/202009:15PRNUSOramed Pharmaceuticals Inc. Prices Public Offering of Common..
2/26/202016:14EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/26/202016:05PRNUSOramed Pharmaceuticals Inc. Announces Proposed Public..
2/26/202008:04EDGARCurrent Report Filing (8-k)
2/26/202008:00PRNUSOramed Reports Positive Results in the Final Cohort of Its..
2/14/202011:56EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202011:47EDGARStatement of Ownership (sc 13g)
2/11/202006:01EDGARNotice of Effectiveness (effect)
2/10/202017:29EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
2/04/202008:25PRNUSOramed to Present at BIO CEO & Investor Conference
1/31/202016:09EDGARSecurities Registration Statement (simplified Form) (s-3)
1/30/202007:25PRNUSOramed Appoints Dr. Julio Rosenstock to Its Scientific..
1/28/202007:25PRNUSOramed Patent in Europe to be Granted for Oral Delivery of..
1/23/202008:00PRNUSOramed Elects Dr. Alexander Fleming to Scientific Advisory..
1/21/202014:41EDGARAmended Statement of Ownership (sc 13g/a)
1/21/202007:25PRNUSOramed Appoints Dr. Jay Skyler to Scientific Advisory Board
1/09/202015:58EDGARQuarterly Report (10-q)
See more news about this stock »


Your Recent History
NASDAQ
ORMP
Oramed Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.